Where science
meets industry

From development to global manufacturing

In GP Pharm we specialize in the research, development, and production of injectable pharmaceutical products. Particularly noteworthy is our company’s extensive experience in the development and manufacture of pharmaceutical products based on sustained-release drug delivery systems: microspheres, liposomes, lipid nanoparticles, and micellar solutions.

Our research and development laboratories possess the most innovative technologies which, together with a highly qualified team, allow for the development and manufacture of a wide spectrum of products, successfully executing our company’s various projects.

CDMO

Excellence in CDMO services

Excellence in CDMO services

Products

Sterile injectable pharmaceutical products in bulk and finished form, based on:

  • Cytotoxic active ingredients.
  • Highly potent active pharmaceutical ingredients (HPAPIs) such as peptides, oligonucleotides, hormones, etc.
  • Intermediate potency active ingredients.
  • Buffer and/or reconstitution solutions.
  • Sustained-release drug delivery systems: microspheres, liposomes, and micellar solutions.

Dosage forms

  • Vials
  • Ampoules
  • Pre-filled syringes
  • Pens

Formulations

  • Liquids
  • Lyophilized products

Authorized for the manufacture of research, preclinical, and validation batches, as well as injectable pharmaceutical products in solution and lyophilized forms.

Our industrial plant and quality system comply with the requirements of Annex 13 of the cGMP, which allow the manufacture of clinical batches.